Table 1

Characteristics of US Buprenorphine Prescribers Across Locations of Practice

Large Metropolitan AreaSmall Metropolitan AreaNonmetropolitan AreaNχ2 or FP Value
Medical specialty, No. (%)1,14939.09<.001
 Primary care215 (33.4)162 (42.9)78 (60.9)
 Addiction/psychiatry353 (54.9)171 (45.2)36 (28.1)
 Other75 (11.7)45 (11.9)14 (10.9)
Practice, No. (%)1,15522.07<.001
 Individual medical practice361 (55.6)183 (48.4)43 (33.6)
 Other288 (44.4)195 (51.6)85 (66.4)
Years prescribing buprenorphine, mean (SD)7.0 (3.9)a,b6.4 (3.9)6.1 (3.7)1,1244.90.008
Waiver type, No. (%)1,1745.50.06
 30-patient limit296 (44.8)143 (37.4)57 (43.2)
 100-patient limit364 (55.2)239 (62.6)75 (56.8)
Payment type for office visits, No. (%)1,14136.61<.001
 Cash only140 (21.9)67 (17.9)16 (12.4)
 Private insurance but not Medicaid170 (26.7)88 (23.5)14 (10.9)
 Medicaid (with or without private insurance)292 (45.8)205 (54.8)95 (73.6)
 Other36 (5.6)14 (3.7)4 (3.1)
Age, mean (SD), y55.3 (12.1)55.4 (10.7)56.4 (9.4)1,1640.51.60
Sex, No. (%)1,1652.13.35
 Male493 (75.5)300 (78.9)105 (79.5)
 Female160 (24.5)80 (21.1)27 (20.5)
Race, No. (%)1,14818.70.001
 White466 (72.0)302 (81.0)110 (85.9)
 Asian100 (15.5)34 (9.1)10 (7.8)
 Other81 (12.5)37 (9.9)8 (6.3)
Census division, No. (%)1,17481.66<.001
 New England62 (9.4)47 (12.3)17 (12.9)
 Middle Atlantic143 (21.7)37 (9.7)15 (11.4)
 East North Central81 (12.3)49 (12.8)21 (15.9)
 West North Central17 (2.6)17 (4.5)6 (4.5)
 South Atlantic129 (19.5)85 (22.3)16 (12.1)
 East South Central24 (3.6)34 (8.9)14 (10.6)
 West South Central45 (6.8)29 (7.6)5 (3.8)
 Mountain31 (4.7)44 (11.5)11 (8.3)
 Pacific128 (19.4)40 (10.5)27 (20.5)
  • US = United States.

  • Note: Groups were compared using analysis of variance (F statistic) or χ2 tests. Percentage may not sum to 100% due to rounding. Not all prescribers responded to all items; the N column represents the number of prescribers with valid data for each item.

  • a Significant difference with Bonferroni correction between physicians in large metropolitan areas and small metropolitan areas.

  • b Significant difference with Bonferroni correction between physicians in large metropolitan areas and nonmetropolitan areas.